No Data
No Data
What Does the Market Think About Chemours?
The Chemours Company (NYSE:CC) Delivered A Better ROE Than Its Industry
RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Maintains Target Price $25
Trump Signs Executive Order to Boost U.S. Critical Mineral Production
Should You Be Excited About The Chemours Company's (NYSE:CC) 14% Return On Equity?
Chemours, Energy Fuels Team Up to Advance Domestic Rare Earth Production